• Return to Headlines

23.5% Return Seen to Date on SmarTrend Insys Therapeuti Call (INSY)

By James Quinn

SmarTrend identified a Downtrend for Insys Therapeuti (NASDAQ:INSY) on January 10th, 2018 at $9.31. In approximately 4 months, Insys Therapeuti has returned 23.52% as of today's recent price of $7.12.

In the past 52 weeks, shares of Insys Therapeuti have traded between a low of $4.10 and a high of $19.96 and are now at $7.12, which is 74% above that low price. In the last five trading sessions, the 50-day moving average (MA) has fallen 1.3% while the 200-day MA has slid 2.1%.

Insys Therapeutics, Inc. develops cancer support drugs. The Company support care candidates include a fast-acting sublingual spray for cancer pain and a dronabinol product used to treat chemotherapy-induced nausea and vomiting and to stimulate appetite in AIDS patients.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Insys Therapeuti.

Log in and add Insys Therapeuti (INSY) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights insys therapeuti

Ticker(s): INSY